Praxis Precision Medicines (PRAX) Cash from Operations (2019 - 2026)

Praxis Precision Medicines' Cash from Operations history runs 8 years deep, the most recent figure standing at 86152000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 62.52% year-over-year to 86152000.0 in Q1 2026; TTM through Mar 2026 was 282210000.0, a 72.17% decrease from a year earlier, with the FY2025 full-year figure at 249068000.0, down 89.04% from the prior year.
• Cash from Operations fell to 86152000.0 in Q1 2026 per PRAX's latest filing, from 76325000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 20857000.0 in Q1 2024 and bottomed at 86152000.0 in Q1 2026.
• The 5-year median for Cash from Operations is 44919000.0 (2022), against an average of 44891529.41.
• Across the five-year window, Cash from Operations soared 48.32% in 2023 and sank 154.16% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 28806000.0 in 2022, then rose by 17.17% to 23861000.0 in 2023, then sank by 135.2% to 56122000.0 in 2024, then tumbled by 36.0% to 76325000.0 in 2025, then retreated by 12.88% to 86152000.0 in 2026.
• Per Business Quant, the three latest PRAX Cash from Operations figures stand at 86152000.0 (Q1 2026), 76325000.0 (Q4 2025), and 65057000.0 (Q3 2025).